Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Clomiphene citrate
evidence profile

Selective estrogen receptor modulator medicine. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Clomiphene citrate: conceptual scientific illustration for Clinical / Endocrine Pharmacology
VISUAL GUIDE · Clomiphene citrate

Clinical / Endocrine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

Clomiphene citrate is classified here as Selective estrogen receptor modulator medicine. Prescription labels support bounded ovulatory-dysfunction use; off-label endocrine use is not equivalent to an approved indication. U.S. prescription labels exist for defined female infertility contexts; WADA prohibits clomifene at all times under hormone and metabolic modulators. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.

01

ENTITY FACTS

What should readers identify first?

MOLECULEClomiphene citrate
PHARMACOLOGYSelective estrogen receptor modulator medicine
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICClinical / Endocrine Pharmacology
LAST REVIEWED2026-09-01

What remains unknown?

Insufficient data in the current dataset

What limits these conclusions?

  • Clomiphene citrate molecule or active moiety ≠ ester/salt ≠ formulation ≠ brand ≠ supplier product; biological plausibility or historical use ≠ current approval ≠ safe performance use

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. DailyMed · Clomiphene citrate human drug-label inventory
  2. FDA · Why unapproved drugs require product-specific review
  3. WADA · 2026 Prohibited List
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Clomiphene citrate?

Clomiphene citrate is described pharmacologically as Selective estrogen receptor modulator medicine. Clomiphene citrate is classified here as Selective estrogen receptor modulator medicine. Prescription labels support bounded ovulatory-dysfunction use; off-label endocrine use is not equivalent to an approved indication. U.S. prescription labels exist for defined female infertility contexts; WADA prohibits clomifene at all times under hormone and metabolic modulators. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions.

Does Clomiphene citrate have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Clomiphene citrate approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice